C4d immunostaining in acute humoral rejection after ABO blood group-incompatible liver transplantation

Liver Transplantation

Volumn 12, Issue 3, 2006, Pages 356-357

  Neuman, Ulf P ^a   Neuhaus, Peter ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; PROSTAGLANDIN E1; RITUXIMAB;

ACUTE GRAFT REJECTION; ANTIGEN EXPRESSION; BILIARY TRACT DISEASE; BLEEDING TENDENCY; BLOOD GROUP ABO INCOMPATIBILITY; CHOLANGITIS; CLINICAL PROTOCOL; EDITORIAL; GRAFT SURVIVAL; HUMAN; HUMORAL IMMUNITY; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; LIVER DISEASE; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; PLASMAPHERESIS; POSTOPERATIVE PERIOD; PREDICTION; PRIORITY JOURNAL; SPLENECTOMY;

ABO BLOOD-GROUP SYSTEM; BIOLOGICAL MARKERS; BLOOD GROUP INCOMPATIBILITY; COHORT STUDIES; COMPLEMENT C4B; FEMALE; GRAFT REJECTION; HUMANS; LIVER TRANSPLANTATION; MALE; PEPTIDE FRAGMENTS; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY;

EID: 33645287293     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.20658     Document Type: Editorial

References (8)

1. Farges O, Kalil AN, Samuel D, Saliba F, Arulnaden JL, Debat P, et al. The use of ABO-incompatible grafts in liver transplantation: a life-saving procedure in highly selected patients. Transplantation 1995;59:1124-1333.
2. Mor E, Skerrett D, Manzarbeitia C, Sheiner PA, Schwartz ME, Emre S, et al. Successful use of an enhanced immunosuppressive protocol with plasmapheresis for ABO-incompatible mismatched grafts in liver transplant recipients. Transplantation 1995;59:986-990.
3. Crespo M, Pascual M, Tolkoff-Rubin N, Mauiyyedi S, Collins AB, Fitzpatrick D, et al. Acute humoral rejection in renal allograft recipients: I. Incidence, serology and clinical characteristics. Transplantation 2001;71:652-658.
4. Crespo M, Lozano M, Sole M, Mila J, Esforzado N, Martorell J, et al. Diagnosis and treatment of acute humoral rejection after kidney transplantation: preliminary experience. Transplant Proc 2003;35:1677-1678.
5. Feucht HE, Felber E, Gokel MJ, Hillebrand G, Nattermann U, Brockmeyer C, et al. Vascular deposition of complement-split products in kidney allografts with cell-mediated rejection. Clin Exp Immunol 1991;86:464-470.
6. Feucht HE, Schneeberger H, Hillebrand G, Burkhardt K, Weiss M, Riethmuller G, et al. Capillary deposition of C4d complement fragment and early renal graft loss. Kidney Int 1993;43:1333-1338.
7. Hanto DW, Fecteau AH, Alonso MH, Valente JF, Whiting JF. ABO-incompatible liver transplantation with no immunological graft losses using total plasma exchange, splenectomy, and quadruple immunosuppression: evidence for accommodation. Liver Transpl 2003;9:22-30.
8. Krukemeyer MG, Moeller J, Morawietz L, Rudolph B, Neumann U, Theruvath T, et al. Description of B lymphocytes and plasma cells, complement, and chemokines/receptors in acute liver allograft rejection. Transplantation 2004;78: 65-70.